NeuBase Therapeutics (NASDAQ: NBSE), a notable player in genetic neurological disorder treatments, experienced a bumpy ride in the stock market last Friday. Initially taking a
NeuBase Therapeutics Inc. (NBSE) closed Friday’s after-hours trading at $5.87, up 9.72%. NeuBase’s stock price finished last trading session up 5.31% at $5.35. A range
Shares of the NeuBase Therapeutics, Inc. (NBSE) stock were declining in yesterday’s aftermarket trading session after the spread of the news that Neubase stock announced
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.